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Abstract
Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a velopharyngoplasty. The
functional outcome has been reported to be worse in patients with 22q11.2 deletion syndrome than in patients without the
syndrome. A possible explanation is the hypotonia that is often present as part of the syndrome. To confirm a myogenic
component of the etiology of velopharyngeal insufficiency in children with 22q11.2 deletion syndrome, specimens of the
pharyngeal constrictor muscle were taken from children with and without the syndrome. Histologic properties were
compared between the groups. Specimens from the two groups did not differ regarding the presence of increased
perimysial or endomysial space, fiber grouping by size or type, internalized nuclei, the percentage type I fibers, or the
diameters of type I and type II fibers. In conclusion, a myogenic component of the etiology of velopharyngeal insufficiency
in children with 22q11.2 deletion syndrome could not be confirmed.
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Introduction
The 22q11.2 deletion syndrome (22q11.2DS) is the most
common human microdeletion syndrome [1] with an estimated
frequency around 1 in 4000 [2] but possibly as high as 1 in 2000
surviving newborns [3]. It encompasses the phenotypes previously
known as DiGeorge syndrome, velocardiofacial syndrome, con-
otruncal anomaly face syndrome, many cases of the autosomal
dominant Opitz G/BBB syndrome, and Cayler cardiofacial
syndrome (asymmetric crying facies). Over 180 clinical features
including every organ system have been associated with the
deletion [4].
One of the presenting features of 22q11DS is velopharyngeal
insufficiency (VPI). Velopharyngeal insufficiency is the failure of
the soft palate to reach the posterior pharyngeal wall to close the
opening between the oral and nasal cavities, resulting in
hypernasal speech. Incomplete velopharyngeal closure is most
frequently related to structural abnormalities such as cleft palate or
submucous cleft, but may also be the corollary of neuromuscular
impairment [5]. Both seem to be factors in the etiology of VPI in
patients with 22q11.2 deletion syndrome where palatal defects,
adenoid hypoplasia, and platybasia enlarge the pharyngeal gap
[6], and the hypodynamic pharynx as viewed by nasendoscopy has
been described as a ‘‘black hole’’ [7].
Surgical repair of palatal clefts does not sufficiently correct VPI
in 10- 31.8% of all patients with VPI not restricted to those with
22q11DS [8,9,10,11,12], possibly due to stiffness or shrinkage of
the velum due to scarring [5]. Secondary velopharyngoplasty to
correct the VPI may then follow. The functional outcome has
been reported to be worse in patients with 22q11DS than in
patients without the syndrome [13,14,15,16,17,18]. A possible
explanation is the hypotonia that is often present as part of the
syndrome and which cannot be corrected by surgery.
Velopharyngeal closure is achieved by the concert action of
multiple muscles, including palatal lift by the levator veli palatini
and circular pharyngeal closure by the pharyngeal constrictor
muscle (PCM) [19,20]. A previous study of the PCM, shows that
patients with 22q11DS have proportionally more type I fibers and
the diameter of these fibers is smaller than those in people without
the syndrome [21]. In the study by Zim et al, muscle biopsies from
children were compared with specimens from elderly cadavers.
Muscle fiber hypoplasia or atrophy with subsequent pharynx
hypotonia may be primarily myogenic or neurogenic. Muscular
and neurologic problems have been associated with 22q11DS both
clinically and genetically. Specific myopathies are rare [22,23,24],
but neurologic disorders including delayed motor and mental
development [25,26,27] and dysfunction of cranial nerves III, VII,
VIII, IX, X, and XII [28] affect at least 33% of patients [29,30].
General hypotonia, which affects 23-76% of patients with
22q11DS [29,31,32], was found to be universally prevalent among
children with 22q11DS and VPI [33].
About 40 genes [3], including TBX1, are located in the 3.0
megabase region deleted in 22q11DS [1], affecting countless
downstream signaling pathways. The central roles of the TBX1
and CRKL genes in the anomalous developmental of pharyngeal
structures in 22q11DS have recently been reviewed [34]. The
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meric muscles [35,36], but the sporadic muscles that develop have
a normal distribution of muscle fibers types [37]. In patients with
22q11DS, decreased PCM muscle thickness on MRI [21] suggests
hypoplasia. The temporal Tbx1 gradient follows the cranial-
caudal development of pharyngeal structures [36], causing
structures that are derived from more cranially located pharyngeal
arches, such as the levator palatini muscles, to be less affected by
the mutation than structures derived from more caudally located
pharyngeal arches, such as the PCM muscle [38,39]. Although
Tbx1 is not expressed in primary neural crest cells [40], Tbx1
mutants have aberrant structures derived from neural crest cells
including cranial nerves [38] since defective Tbx1 expression in
the pharyngeal endoderm affects the downstream expression Fgf8
and Fgf10 which are necessary for neural crest cell migration
[38,41,42]. As suggested by studies on the deleted TBX1 gene
[35,37,38], primary aberrant myogenesis leads to aberrant
neurogenesis.
In summary, the poorer functional outcome after velophar-
yngoplasty in patients with 22q11DS may be attributed to
pharyngeal hypotonia. Anomalous myogenesis and neurogenesis
which may underlie the hypotonia have been reported in a murine
model for 22q11DS. In this study we aimed to confirm a myogenic
component of the etiology of VPI in children with 22q11DS by
analyzing the histology of the PCM muscle. Our clinical
experience is that the PCM seems thicker in children with
22q11DS. We expect to find fiber hypertrophy as a corollary of the
muscle hypoplasia [35,36] necessitating the few fibers present to
take on a heavier workload.
Methods
Ethics Statement
This study was approved by the institutional medical ethics
review board (Utrecht University Medical Center Ethics Review
Board) and the patients’ parents gave written informed consent to
participate.
Patients
The University Medical Centre in Utrecht is the Dutch national
centre for children with 22q11DS. Children undergoing velophar-
yngoplasty for VPI with and without the 22q11DS were included
in the study. Children with contra-indications for velopharyngo-
plasty (including bleeding disorders or extensive comorbidity such
as cardiac problems) and known neurological disorders were
excluded.
Sample size calculation
Using the results of the only previous study on PCM histology in
22q11DS [21] which found a difference of mean diameter of type I
fibers of 5.0 mm between patients with and without 22q11DS, with
a standard deviation of 2.0 mm, an alpha of 0.05, and a power of
0.80 in the two-tailed two-sample t-test sample size formula yields
a sample size of 4 subjects in each group. This number was
arbitrarily doubled as the difference between two groups of
children is likely smaller than the difference between children and
adults in the previous study.
Muscle specimens
During velopharyngoplasty, a cranially attached pharyngeal
flap (measuring around 10640250 mm) is mobilized from the
dorsal pharyngeal wall and attached to the velum. This flap is
comprised of part of the PCM muscle and the overlying mucosa.
Muscle at the caudal end of the flap is trimmed (measuring around
1063 mm) and delivered fresh to the pathologist in a damp gauze
for histological evaluation.
Outcome parameters
Histological evaluation of the muscle specimens included
qualitative analysis and quantitative measurements. The analysts
were blinded for age, gender and presence of the syndrome. The
specimens were qualitatively evaluated for the presence of increased
perimysial and endomysial space, muscle fiber grouping by size or
type, and presence of internalized nuclei. After staining with
ATPase at pH 4.3, representative areas from each specimen were
photographed.Forquantitativeanalysis, muscle fiberswerecounted
and the percentage of type I muscle fiber was calculated per patient.
The diameters of up to 100 fibers of each type were measured for
each patient. For each muscle fiber type, the mean fiber diameter
and variance ((SD61000)/mean diameter) were calculated per
group (males, females, and children with and without 22q11DS).
Statistical analysis
The genders of children with and without 22q11DS were
compared using the Chi-square test. Age at surgery of males and
females and children with and without 22q11DS were compared
using the Independent samples t-test. The presence of increased
perimysial and endomysial space, muscle fiber grouping by size and
type, and internalized nuclei was compared between the two groups
Figure 1. Group demographics. O: males, X: females.
doi:10.1371/journal.pone.0021672.g001
Table 1. Qualitative analyses.
Parameter
22q11DS
(n=8)
No 22q11DS
(n=8) p
Increased perimysial space, No. (%) 5 (63) 5 (63) 1
Increased endomysial space, No. (%) 4 (50) 6 (75) 0.61
Grouping by size, No. (%) 0 (0) 1 (13) 1
Grouping by fiber type, No. (%) 0 (0) 0 (0) 1
Internalized nuclei, No. (%) 1 (13) 0 (0) 1
doi:10.1371/journal.pone.0021672.t001
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fiber diameters was examined using the Spearman correlation. The
independent samples t-testwas used to compare the mean percentage
oftype I fibersand muscle fiber diametersbetweenmalesand females
and between children with and without 22q11DS.
Results
Patients
Muscle specimens were available for 16 children, eight with
22q11DS and eight without 22q11DS. The groups did not differ
regarding gender (5/8=63% and 4/8=50% female, respectively,
p=0.63) or age at surgery (6.5 and 7.0 years, respectively,
p=0.68) (Figure 1). Males and females did not differ regarding age
at surgery (7.4 and 6.2 years, respectively, p=0.39).
Qualitative analysis
No structural differences were seen between histological
specimens from children with and without 22q11DS (Table 1,
Figure 2). Increased perimysial and endomysial space was seen
equally in both groups. No grouping by muscle fiber type was
seen in any patient. One non-syndromic patient had localized
grouping of smaller fibers, but these were round fibers without
nuclear clumping which do not suggest neurogenic atrophy or
other signs of fiber degeneration and regeneration. One patient
with 22q11DS had an increased percentage of internalized
nuclei.
Quantitative measurements
There was no correlation between muscle fiber diameter and
age at surgery (p=0.78 for type I fibers and p=0.48 for type II
fibers, Figure 3). Neither the percentage of type I fibers nor the
diameters of the fiber types differed significantly between males
and females or between children with and without 22q11DS
(Table 2, Figure 4). All calculated fiber diameter variances were
less than 250 (Table 2). For all groups, the mean diameters of type
I fibers were more than 12% smaller than the mean diameters of
the larger type II fibers.
Figure 2. Histological specimens with ATPase stain at pH 4.3. A, a 5-year-old female without 22q11DS but with increased perimysial and
endomysial space. B, a 10-year-old male with 22q11DS and without increased perimysial and endomysial space. Bars 50 mm.
doi:10.1371/journal.pone.0021672.g002
Figure 3. Mean diameters of type I (A) and type II (B) muscle fibers and age at surgery. Solid lines: males, dashed lines: females.
doi:10.1371/journal.pone.0021672.g003
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Few studies have looked at the histology of the PCM. With the
exception of specimens obtained from patients undergoing
pharyngoplasty [21] or laryngectomy [43], most only study
specimens from cadavers.
Morphology
Our qualitative analysis revealed no morphologic differences
between PCM muscles in children with and without 22q11DS
(Table 1). We found increased perimysial and endomysial
space in both groups. While increased space is associated with
chronic muscle damage, it is unclear whether this is also true
for pharyngeal constrictors. Since it affects both groups
equally, it is unlikely to be a factor in the poorer speech in
children with 22qDS. Zim et al. [21] found increased
endomysial space in children with 22q11DS relative to adults
without the syndrome, but did not test the difference for
significance. Like Zim et al. [21], we did not find any grouping
by muscle fiber type, indicating the absence of innervation
distubances.
Fiber type
We found 30.6% (SD 12.3) and 25.7% (SD 10.5) type I
muscle fibers, respectively, in children with and without
22q11DS. Zim et al. [21] found 27.7% (SD 2.01) and 17.9%
(SD 2.15) type I muscle fibers, respectively, in children with
and adults without 22q11DS. The significant difference
between the groups in the study by Zim et al. may not
necessarily be attributed to the presence of the syndrome, but
may be distorted by the unusually small percentage of type I
fibers found in the adult controls (81–86 years, cadavers).
Other studies on pharyngeal constrictor specimens in adults
found 35% (43–77 years, live) [43], 49% (SD 9.2) (38–61 years,
cadavers) [44], and 33.7% (SD 12.0) (over 50 years, cadavers)
[45] type I fibers. Leese and Hopwood [45] report 20.4% (SD
8.7) type I fibers in infants (0–3 years) and 30.2% (SD 15.3)
type I fibers in young adults (12–49 years). While they report
Table 2. Quantitative analyses.
Parameter Male Female
Mean
difference
(95% CI) p 22q11DS No 22q11DS
Mean
difference
(95% CI) p
Type I fibers, % (SD) 24.8 (10.3) 30.7 (11.9) 26( 218, 6) 0.43 30.6 (12.3) 25.7 (10.5) 4.9 (27, 17) 0.46
Type I fiber diameter, mm (SD), 20.6 (3.9), 18.5 (4.3), 2 (22, 7) 0.32 19.3 (3.7), 19.6 (4.8), 20.3 (25, 4) 0.92
variance 189 232 192 245
Type II fiber diameter, mm (SD), 24.8 (2.6), 23.3 (3.3), 2 (22, 5) 0.37 24.7 (2.8), 23.3 (3.4), 1.4 (22, 5) 0.25
variance 105 142 113 146
doi:10.1371/journal.pone.0021672.t002
Figure 4. Muscle fiber type measurements for children with and without 22q11DS. Bands, means. Boxes, 25
th–75
th percentiles. Whiskers,
95% confidence intervals.
doi:10.1371/journal.pone.0021672.g004
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infant muscle fibers exhibit a significantly lesser percentage of
type I fibers.
Fiber diameter
Previous reports on the mean diameter of type I muscle fibers
in pharyngeal constrictor muscles in adults without 22q11DS
range from 26.6 to 29 mm [21,44]. In children without
22q11DS we found a mean diameter of 19.6 mm( S D4 . 8 ) .I n
children with 22q11DS, Zim et al. [21] found a mean diameter
of 21.6 mm (SD 2.09) and we found a mean diameter of
19.3 mm (SD 3.7). It is tempting to conclude that, as with limb
muscles, mean fiber diameter is related to age [46]. However,
we did not find a correlation between age and diameter among
children of different ages (Figure 3) and Leese and Hopwood
[45] failed to find a relationship among adults of different ages.
They did find a significant difference between fiber diameters
in infants (0–3 years) and adults (over 12 years). Like Leese and
Hopwood [45], we found no difference in fiber diameter
between males and females, reflecting similar usage of the
muscles by both genders.
The similar diameters of both type I and II muscle fibers in
children with and without 22q11DS found in this study reflect
similar strain put on this muscle by all children with VPI.
Unfortunately, we did not have a control group of PCM specimens
from children without VPI. Presumably, children without
structural abnormalities that lead to VPI will have smaller muscle
fiber diameters as they have do not have to employ the pharyngeal
muscles as vigorously to close the oropharynx off from the
nasopharynx.
Fiber type disproportion, reflected in a difference between the
mean fiber type diameters of more than 12% of the mean
diameter of the larger fiber type, is characteristic of congenital
myopathies [46]. In this study, the type II fibers were more than
12% larger than the type I fibers in both children with and without
22q11DS. In the study by Zim et al. [21], the diameters of the type
II fibers were also more than 12% larger than the type I fibers in
children with 22q11DS, while the muscle fiber types had similar
diameters in adults without 22q11DS. The disproportion is likely a
result of selective type II hypertrophy rather than type I atrophy as
children with VPI place extra strain on the fast type II fibers while
attempting to articulate properly and preventing nasal regurgita-
tion while swallowing.
We found greater variance in muscle fiber diameter (192 and
113) than Zim et al. [21] (97 and 77, respectively, for type I and II
fibers in children with 22q11DS). Our measurements are based on
more fibers per patient (171 to 200) than the study by Zim et al.
[21] (64 to 113 fibers per patient). We found greater variance
among children without 22q11DS (245 and 146, respectively, for
type I and II fibers), but no groups had variances greater than 250,
which is considered pathologic in limb muscles, but has been
found in healthy palatal muscles [47].
Conclusion
Therefore, we conclude that there is no evidence of innervation
or myogenic disturbances in the histologic specimens of the PCM
in children with 22q11DS relative to non-syndromic counterparts.
The absence of histologic deficits in the PCM muscle of patients
with 22q11DS does not preclude the functional deficits manifest in
the hypodynamic pharynx seen on nasendoscopy and poorer
functional outcome after velopharyngoplasty. Future studies to
elucidate the etiology of the pharyngeal hypotonia in 22q11DS
should investigate the role of the central nervous system, such as by
comparing fMRI images taken during speech. Meanwhile,
unanswered etiologic and clinical questions hamper adequate
management of the compromised speech understandability in
patients with 22q11DS, contributing to poor social functioning
and quality of life.
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